Yahoo! Finance Search - Finance Home - Yahoo! - Help

Sunday, February 7 2016 8:03am ET - U.S. Markets Closed.
Industry Center - Biotechnology
Industry Center > Biotechnology > News
More On This Industry
· Summary
News
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Major
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Biotechnology
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Conglomerates
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
 
Biotechnology News
Latest News
Sunday, Feb 7, 2016
·Biogen Inc. Takes Aim at Johnson & Johnson
at Motley Fool - 43 minutes ago
·Shares of Incyte Corporation Plummeted in January -- Here's Why
at Motley Fool - 55 minutes ago
Saturday, Feb 6, 2016
·2 Beaten-Down Biotech Stocks to Buy in February
at Motley Fool - Sat 3:21 pm ET
·How Analysts Value Gilead Now After Earnings
- Sat 10:50 am ET
·Grading Gilead Sciences' Performance in 2015
at Motley Fool - Sat 9:41 am ET
·1 Company Gilead Sciences Should Consider Buying Right Now
at Motley Fool - Sat 9:40 am ET
·Are Zika Virus Fears Being Blown Out of Proportion?
at Motley Fool - Sat 9:12 am ET
·Why Ophthotech Corporation Shares Tumbled 31% in January
at Motley Fool - Sat 8:40 am ET
·Why Share of Novavax Inc Dropped 34% in January
at Motley Fool - Sat 8:06 am ET
·The Silly Reason Why Agios Pharmaceuticals Inc. Was Clobbered in January
at Motley Fool - Sat 7:32 am ET
·Why Halozyme Therapeutics Inc Plunged 51% in January
at Motley Fool - Sat 7:06 am ET
·This Weekend's Barron's: Could Oil Drop to $20 a Barrel ~ Mutual Fund Family Rankings ~ Worst May Not Be Over for MLP Investors Undervalued Drugmakers With Lots of Upside
at Barrons.com - Sat 1:06 am ET
·[$$] Celgene and Gilead: Two Drugmakers, 30% Upside
at Barrons.com - Sat 12:01 am ET
·ESPERION THERAPEUTICS, INC. SHAREHOLDER REMINDER: Kessler Topaz Meltzer & Check, LLP Reminds Esperion Therapeutics, Inc. Shareholders of Class Action Lawsuit - ESPR
- Sat 12:01 am ET
·Kessler Topaz Meltzer & Check, LLP Files Shareholder Class Action Against Insys Therapeutics, Inc. - INSY
- Sat 12:01 am ET
Friday, Feb 5, 2016
·The Former Attorney General of Louisiana & Kahn Swick & Foti, LLC Remind Large Investors of Lead Plaintiff Deadline in Class Action Lawsuit Against Insys Therapeutics, Inc. - INSY
GlobeNewswire - Fri 10:00 pm ET
·INVESTOR NOTICE: Goldberg Law PC Files Securities Class Action Lawsuit against INSYS Therapeutics, Inc. and Strongly Encourages Investors to Contact the Firm
Business Wire - Fri 7:07 pm ET
·IMPORTANT INVESTOR NOTICE: Lundin Law PC Announces Ongoing Investigation of Anavex Life Sciences Corp. and Urges Investors with Losses in Excess of $250,000 to Contact the Firm
Business Wire - Fri 7:01 pm ET
·3 trades to watch as stock pain continues
at CNBC - Fri 6:40 pm ET
·The Key Takeaways From Alexion Pharmaceuticals Inc.'s Earnings Release
at Motley Fool - Fri 5:56 pm ET
More Latest News...
  

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Biotechnology Headlines
More Finance RSS Feeds


Copyright © 2016 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2016 Morningstar, Inc. All Rights Reserved. Company information © 2016 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2016, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?